Skip to main content
logo
Bicycle Therapeutics logo
Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
3.635
-0.165 (-4.34%)
Oct 13, 2026, 4:00 PM EDT - Market closed

Bicycle Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2544919677678791,790
Market Cap Growth
-55.94%-49.19%26.03%-12.72%-50.89%367.95%
Enterprise Value
-241-151872415611,563
Last Close Price
3.807.0814.0018.0829.6060.87

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.256.7727.4028.4360.76152.99
PB Ratio
0.520.811.222.073.255.17
P/TBV Ratio
0.510.811.222.073.255.17

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--2.468.9238.82133.63

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.010.120.160.13
Net Debt / Equity Ratio
-0.97-1.00-1.10-1.30-1.09-1.14
Net Debt / EBITDA Ratio
2.472.594.322.632.616.14
Net Debt / FCF Ratio
2.382.425.247.582.8123.44
Asset Turnover
0.090.090.050.050.030.04
Quick Ratio
11.7011.6513.617.926.7612.43
Current Ratio
12.0811.9813.818.086.9312.65
Return on Equity (ROE)
-32.30%-31.21%-29.04%-56.31%-36.54%-30.25%
Return on Assets (ROA)
-17.91%-18.13%-16.81%-23.60%-16.38%-12.80%
Return on Capital Employed (ROCE)
-36.90%-36.80%-23.50%-36.10%-32.70%-14.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-73.13%-44.58%-17.49%-23.55%-12.83%-3.73%
FCF Yield
-79.99%-51.32%-17.17%-8.29%-11.96%-0.94%
Buyback Yield / Dilution
-0.52%-19.02%-63.54%-20.00%-18.35%-30.90%
SEC Filings: 10-K · 10-Q